About this episode

In this episode, Robert Schoevers discusses his work on psychedelic-assisted therapy and its application in palliative care.

Join us in this episode as we talk to Robert Schoevers, a professor of psychiatry at the University of Groningen and one of the pioneers of psychedelic-assisted therapy. He explains why human complexity led him to psychiatry, begoring discussing how his early psychedelic research into esketamine aimed to meet the unmet needs of treatment-resistant patients. Schoevers goes on to explore the ways in which his approach to ketamine-assisted therapy has transitioned over time and has led him to lead bigger projects, like the EU-funded palliative care project, PsyPal. Links Profile Ketamine Compass Paper PsyPal ★ Support this podcast ★

People in this episode

Guest: Robert Schoevers

Topics covered

• psychedelics
• palliative care
• psychiatry
• therapy
• treatment-resistant patients

Keywords

• psychedelics
• palliative care
• ketamine
• esketamine
• psychiatry
• therapy

Mentioned in this episode

Organizations: University of Groningen, PsyPal

Products: esketamine, ketamine

More episodes of The Drug Science Podcast

• 148. Sleep, Dreams and Sigmund Freud with Prof Mark Solms · April 15, 2026 · 54 min
• 147. Rewarding the Human Mind with Dr Harriet De Wit · April 1, 2026 · 42 min
• 146. Vaping in Schools with Hannah Dawes and Dr Rachael Andrews · March 18, 2026 · 54 min
• 145. Psychedelics, Power and the Price of Healing with Erica Rex · March 4, 2026 · 37 min
• 144. On Drugs: Philosophy, Consciousness and Sobriety with Justin Smith-Ruiu · February 18, 2026 · 24 min
• 142. Animal Research and the Future of Depression with Prof Emma Robinson · December 10, 2025 · 1h 1m

Explore listener stats, chart rankings, contacts and more on the The Drug Science Podcast podcast page.